Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs Passage Bio, Inc. (PASG)

Chemomab Therapeutics Ltd. Sponsored ADR and Passage Bio, Inc. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and Passage Bio, Inc. are of similar size ($16.0M and $15.5M). Across the 9 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 6 and Passage Bio, Inc. on 3.

Valuation

Metric CMMB PASG Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.99 3.46 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.23 0.74
EV/Sales n/m n/m 10.73
Earnings yield (37.06%) (235.83%) (28.84%)
Free cash flow yield (210.63%) (236.83%) (23.03%)

Profitability

Metric CMMB PASG Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (82.17%) (169.09%) (57.72%)
Return on assets (70.70%) (69.20%) (49.22%)
Return on invested capital (247.40%) 0.00% 0.00%

Growth

Metric CMMB PASG Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 58.14% 32.94% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMMB PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.41 1.22 4.73
Net debt to EBITDA 1.09 0.96 0.96

Dividend

Metric CMMB PASG Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CMMB PASG Biotechnology median
Market cap 15.95m 15.45m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack